People In The News

NEW YORK (GenomeWeb News) – Molecular diagnostics and cytology test developer Veracyte said this week that it has named Shelly Guyer to be its chief financial officer.

Guyer formerly was CFO and executive VP of finance and administration at iRhythm Technologies, and she was VP of business development and investor relations at the biotech firm Nuvelo. She also spent 17 years at JP Morgan Securities and its predecessor companies, where she led financing for large- and small-cap life sciences firms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.